Download Biotecnika Times Magazine 23rd October Issue

October 23rd, 2018.

Vol. 02

NO 49

www.biotecnika.org

Call:1800-200-3757

Voice of BioTecNika Episode 1

Important Notice From CSIR Regarding Issue of Certificates

BIT Mesra PhD Program Session Spring (January) 2019 Admissions

Voice of Botecnika

News

Ph.D. Admissions

Page 3

Page 8

Page 5

Junior Research Fellowship JRF 2019 for PhD in Life Sciences at the Tata Memorial STIPEND: RS. 25000/- + 30 PERCENT HRA (IF HOSTEL FACILITY ISN’T ALLOTTED) A MONTH AS APPLICABLE. LIMITED HOSTEL FACILITY IS ON THE ACTREC CAMPUS ON A FIRST COME, FIRST SERVED BASIS.

By Diluxi Arya

The Tata Memorial Centre (TMC) is an autonomous Grant-in-aid Institution at the Department of Atomic Energy. The TMC is comprised of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) and the Tata Memorial Hospital (TMH). TMC conducts a PhD program in Life Sciences and is affiliated to the Homi Bhabha National Institute (Deemed University). On-going research at TMC includes basic and translational research in Cancer Biology. Specific research topics include the

Read more on Page 2

IIT DELHI ADMISSION PHD/MS (RESEARCH) PROGRAMMES 2018-2019

●● IIT Delhi ADMISSION TO Ph.D./ M.S.(RESEARCH) PROGRAMMES 2018-2019 (2nd Semester) announcement has been made. MSc and PhD Research Programmes 2018-2019 at IIT Delhi...

Page 6

EXCLUSIVE M.SC. & PH.D. JOBS

study of cell proliferation, differentiation, apoptosis, metastasis, tumour immunology, molecular imaging, carcinogenesis, stem cell biology, biophysics, structural biology, bioinformatics, proteomics, genomics, genetics, epigenetics and pharmacology.

SVP NATIONAL POLICE ACADEMY RECRUITMENT WITH RS. 1.7 LAKH SALARY PM

Qualifications: M.Sc (Applied Biology / Biochemistry / Bioinformatics / Biophysics / Biotechnology / Botany / Life Sciences / Microbiology/ Molecular Biology / Zoology or associated Biological Sciences) / M.Tech. (Bioinformatics/ Biotechnology); M.V.Sc.; M.Pharm. from a recognized University, with ≥ 50% aggregate marks. Those awaiting results may also apply. According to HBNI guidelines, candidates with < 50% aggregate marks...

SUBSCRIBE TO BIOTECNIKA TIMES ON WHATSAPP-CLICK HERE

Ph.D. ADMISSIONS

●● Government jobs for msc botany, zoology, microbiology, biochemistry, biology scientific officer vacancies at SVP National Police Academy, Hyderabad. Sardar Vallabhbhai Patel National Police Academy...

Page 10

NEWS NOVARTIS ACQUIRES ENDOCYTE FOR 2.1 BILLION CASH DEAL

EXCLUSIVE M.SC. & PH.D. JOBS MSC OFFICER QUALITY CONTROL POSTS VACANT @ JUBILANT GENERICS LIMITED ●● MSc Microbiology Jobs at Jubilant Generics Limited. Jubilant Generics Limited Hiring for Officer Quality Control Position. Officer Quality Control post for msc microbiology candidates. MSc microbiology jobs with relevant experience for eligible candidates...

Page 11

●● Shares of Indiana-based Endocyte have taken up more than 50 percent in pre-market trading following Swiss pharma giant Novartis declared that it was acquiring the company for $2.1 billion in cash...

Page 8

2

HEADLINES

October 23rd, 2018 Vol. 02 NO 49

Junior Research Fellowship JRF 2019 @ Tata Memorial Centre The Centre is the national comprehensive cancer centre for the prevention, treatment, education and research in Cancer and is recognized as one of the leading cancer centres in this part of the world. Its a fully funded Grant-in-Aid Institution of Department of Atomic Energy, which also oversees the administration of institute since 1962. or speed post at the address provided. Female applicants and SC/ ST/ physically disabled applicants with minimum 40% handicap (disability proof has to be attached) are exempted from paying fees. Students have to give three choices of Exam Centre within their application. Final admission into the PhD program is subject to the candidate satisfying HBNI eligibility criteria as stated above. TMC reserves the right to raise the minimum eligibility standards in the event of receipt of a large number of applications. The deadline for application is 24th December 2018.

APPLICATIONS ARE INVITED, IN THE PRESCRIBED FORMAT, FOR ONLINE EXAMINATIONS AND THE AWARD OF JUNI O R R E S E A R C H F E L LO W SHIPS (JRF 2019) FOR PHD IN LIFE SCIENCES AT T H E TATA M E M O R I A L CENTRE

By Diluxi Arya

Interested candidates can check out all of the details qualifications, stipend and application prcodeure below:

differentiation, apoptosis, metastasis, tumour immunology, molecular imaging, carcinogenesis, stem cell biology, biophysics, structural biology, bioinformatics, proteomics, genomics, genetics, epigenetics and pharmacology.

Qualifications: M.Sc (Applied Biology / Biochemistry / Bioinformatics / Biophysics / Biotechnology / Botany / Life Sciences / Microbiology/ Molecular Biology / Zoology or associated Biological Sciences) /

only 1-year duration aren’t eligible.

Stipend: Rs. 25000/- + 30 percent HRA (if hostel facility isn’t allotted) a month as applicable. Limited hostel facility is on the ACTREC campus on a first come, first served basis.

Application Process: Candidates are advised to thoroughly read the instructions before completing the online application [ w w w. actrec. g o v. in].

Eligibility for Direct Interview (Online application for ACTREC JRF 2019 is required ) • Candidates holding legitimate Junior Research Fellowships granted after qualifying in a national level written Entrance test conducted by CSIR/ UGC/ ICMR/ DBT or other established agencies.

• Candidates that receive external fellowship intimation by 30th April 2019 should send proof of this award by email [jrf2019@actrec.gov.in] to seek direct interview dates.

TATA MEMORIAL CENTRE Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Kharghar, Navi Mumbai – 410 210 & Tata Memorial Hospital (TMH) Parel, Mumbai – 400 012 (A Grant-in-Aid Institution of the Department of Atomic Energy, Government of India)

• Candidates that feature in ACTREC’s short list of the Joint Graduate Entrance Examination for Biology and Interdisciplinary Life Sciences (JGEEBILS) that will be displayed on the ACTREC site.

The listing of candidates found eligible for a direct interview is going to be displayed on the ACTREC site in May 2019.

Applications are invited, in the prescribed format, for online examinations and the award of JUNIOR RESEARCH FELLOWSHIPS [JRF 2019] for Ph.D. in Life Sciences at the Tata Memorial Centre The Tata Memorial Centre (TMC) is an autonomous Grant-in-aid Institution at the Department of Atomic Energy. The TMC is comprised of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) and the Tata Memorial Hospital (TMH). TMC conducts a PhD program in Life Sciences and is affiliated to the Homi Bhabha National Institute (Deemed University). On-going research at TMC includes basic and translational research in Cancer Biology. Specific research topics include the study of cell proliferation,

Online Examination: A list of applicants found eligible for the Online’Objective’ Written Exam will be displayed on 7 Th January 2019 on the ACTREC site. The Online Exam will be conducted on 25th January 2019 at 9.00 a.m. At six Exam Centres located in Mumbai, Pune, Kolkata, Delhi NCR, Indore and Chennai (details will be uploaded on The ACTREC site in January 2019). In case the number of students opting for a centre is under 100, the students Opting for that centre will be accommodated at their second or third choice of centre. The list of candidates Qualifying for interview based on the online examination results will be displayed on the ACTREC site in February 2019.

M.Tech.

(Bioinformatics/ Biotechnology); M.V.Sc.; M.Pharm. from a recognized University, with ≥ 50% aggregate marks.

Those awaiting results may also apply.

According to HBNI guidelines, candidates with < 50% aggregate marks can’t be considered for an interview or admitted to the program. Candidates who’ve done post-graduation course of

I n c o m plete forms and those with no fees and requisite attachments will be rejected. Application fees of Rs. 500/must be compensated by online transfer. In the event of difficulty, fees may be paid by demand draft (DD) drawn in favour of TMC-ACTREC payable Navi Mumbai (candidate’s name and program number should be written behind the DD) and sent to ACTREC-TMC by courier

Interview Dates: Interviews of applicants that have cleared the ACTREC entrance test in Addition to Direct Interviews Will be run at ACTREC in June 2019 — the dates will be displayed on the ACTREC site in May 2019.

Research Projects: The list of JRF projects being offered to PhD students at TMC will be displayed on the ACTREC site in May 2019.

Candidates are invited to interact with and seek information from the Principal Investigators whose titles and e-mail IDs will be cited against their respective projects.

Declaration of the Results: The list of successful applicants will be shown on the ACTREC site.

VOICE OF BIOTECNIKA

October 23rd, 2018 Vol. 02 NO 49

3

Voice of BioTecNika – Episode 1 Hello & Welcome to the very first Episode of Voice of Biotecnika – A Weekly Podcast which is being on launched on the 12th Birthday of Biotecnika.

Yes, you heard it right!

IT IS OUR 12TH BIRTHDAY AND THAT MEANS 12 YEARS AGO ON THIS DATE WE DECIDED TO START BIOTECNIKA AND THE NAME BIOTECNIKA WAS COINED

By Shekhar Suman

Incidentally, Today is the birthday of the Big B of Bollywood Amitabh Bachchan also Truly said he is the Big B of Bollywood and we are the Big B of Biotech. Jokes apart And we are going to give a gift to all our subscribers today: THE VOICE of BioTecNika A weekly Podcast which will be broadcasted every Wednesday to you via our Website, Soundcloud & Our Youtube Channel In this series of Podcast, we will be inviting experts and Policy Makers who are helping shape the destiny of BioSciences

CRISPR-CAS9

A lot has been said and done about Biotecnika in the past and thus today in this very first episode I am going to talk about something which is forward-looking and makes us all FUTURE PROOF

AIML or Artificial Intelligence & Machine learning is an upcoming field and when you combine Biotech & Health tech into this, it’s a jabardast combination

You See Life is just like a bicycle, To keep a balance we must keep moving forward and that means if today on Biotecnika’s 12th birthday I keep talking of our achievement then it will contradict our mission & vision. Our Mission is to Promote Biosciences & our Vision is to be the world’s number one Biosciences Portal.

Well we did what we did and now today lets talk about the future of Biosciences, How does it look?

I am sure the critics will say its grim and those in favor will say its bright. So let’s not get into that debate Let us talk about 2 technologies which are going to shape the very future of not just Biosciences but also the mankind Any guesses?

Yeah yeah You guessed it right!

Artificial Intelligence, Machine Learning &

So let us talk about the 1st one today

Why do I say that?

You this world is full of combinations Each time someone innovates a new combination, he becomes successful When a tire is combined with a prototype of a car, it actually becomes a car.

When you combined the power of the Internet with your intelligence it becomes Biotecnika So in short here is an opportunity for all of us to think in the direction of Artificial Intelligence in Biopharma You see a drug molecule is nothing but the right combination of atoms which has got a binding site to bind to the site of action We have been living in an era where it takes 20 years of R&D to develop one molecule which will be used as a universally acceptable drug All that is going to change with AIML Do you remember when your grandfather used to say how slow the trains moved in

the 19th century? Today’s R&D is same as an old steam engine and AIML is that electric engine which is going to pull the entire generation of Scientists into an era where molecules will be discovered every day and drugs will be rolled out in the market every weekend.

Okay okay You don’t believe me?

So lets do this experiment Close your eyes and listen carefully to what I say Recall 1990’s decade and if I and you were there then, and what if I told you one-day self-driving cars will be a possibility. You will say I am insane.

Isn’t it?

No, I am not insane, I am forward looking & optimistic about your Biotech Future. So trust me when I say AIML is the next big thing in Biotech & Pharma industry We are so positive & confident about this technology that we decided to conduct our first ever virtual conference on Artificial intelligence in Biotech & Healthcare technology which is scheduled for 1st week of December 2018 Now lets come to CRISPR Off late you must have seen or heard a lot of news about CRISPR and how it has the

potential to change the way we treat diseases.

So when we work more on CRISPR Cas9 technology, it’s going to open up newer doors of opportunity & innovation to all of us.

CRISPR is one such technology discovered by our steam engine speed R&D which not just aims to alleviate the suffering of mankind but also make it better.

But these 2 technologies are going to favor you only when you have a prepared mind.

The doors of opportunities won’t open to you unless you are ready for it.

So here are the steps I am going to outline in this very first episode to help you develop a scientific mindset: Step 1: Think Step 2: Research on the topic, Join some courses, attend some conferences, do some networking related to these 2 technologies Step 3: Execute your plan with the resources what you have learned in step 2 Future of Mankind is in your hands Comment with your thoughts below and let us know what you think about it And yes A very Happy Birthday to all of Us and a Special thank you to all of you without whom Biotecnika was never possible

4

VOICE OF BIOTECNIKA

October 23rd, 2018 Vol. 02 NO 49

Noble Prize 2018 in Life Science – The Voice of Biotecnika, Episode 2 Hello everyone!! Welcome back to Biotecnika’s very own show. We bring to you a lot of facts about the recent Nobel awardees in the field of Biosciences and have a look at the work done by Nobel Laureates in the past years.

OUT OF THE 6 FIELDS OF NOBEL PRIZE AWARDED EACH YEAR, THE NOBEL PRIZE GIVEN IN PHYSIOLOGY OR MEDICINE INVOLVES THE FIELD OF LIFE SCIENCE. THIS FIELD HAS BEEN AWARDED 108 TIMES SO FAR TO 214 NOBEL LAUREATES BETWEEN THE YEARS 1901 AND 2017.

By Shekhar Suman

For the running year, the award has been announced on October 1st, 11:30 AM CEST. Let us have a look at the work done

by Nobel Laureates in the past years.

In 2017, Jeffrey Hall, Michael Rosbash, Michael Young, were awarded the Nobel Prize for their discoveries of molecular mechanisms controlling the circadian rhythm. It signifies the internal biological clock that helps us decipher between night and day and regulates our sleep-wake cycle. The above mentioned 3 brilliant minds together peeked behind the workings of this miraculous system and explained how every organism adapt their biological rhythm to the Earth’s revolutions. Using fruit flies as a model organism, this year’s Nobel laureates isolated a gene that controls the normal daily biological rhythm.

They showed that this gene encodes a protein that accumulates in the cell during the night, and is then degraded during the day.

Subsequently, they identified additional protein components of this machinery, exposing the mechanism governing the self-sustaining clockwork inside the cell.

We now recognize that biological clocks function by the same principles in cells of other multicellular organisms, including humans.With exquisite precision, our inner clock adapts our physiology to the dramatically different phases of the day. The clock regulates critical functions such as behavior, hormone levels, sleep, body temperature, and metabolism. Our wellbeing is af-

fected when there is a temporary mismatch between our external environment and this internal biological clock, for example when we travel across several time zones and experience “jet lag”. In 1984, Jeffrey Hall and Michael Rosbash, working in close collaboration at Brandeis University in Boston, and Michael Young at the Rockefeller University in New York, succeeded in isolating the period gene. Jeffrey Hall and Michael Rosbash then went on to discover that PER, the protein encoded by period, accumulated during the night and was degraded during the day. Thus, PER protein levels oscillate over a 24-hour cycle, in synchrony with the circadian rhythm. The next key goal was to understand how such circadian oscillations could be generated and sustained. Jeffrey Hall and Michael Rosbash hypothesized that the PER protein blocked the activity of the period gene.

They reasoned that by an inhibitory feedback loop, PER protein could prevent its own synthesis and thereby regulate its own level in a continuous, cyclic rhythm. The model was tantalizing, but a few pieces of the puzzle were missing. To block the activity of the period gene, PER protein, which is produced in the cytoplasm, would have to reach the cell nucleus, where the genetic material is located. Jeffrey Hall and Michael Rosbash had shown that PER protein builds up in the nucleus during the night, but how did it get there? In 1994 Michael Young discovered a second clock gene, timeless, encoding the TIM protein that was required for a normal circadian rhythm. In elegant work, he showed that when TIM bound to PER, the two proteins were able to enter the cell nucleus where they blocked period gene activity to close the inhibitory feedback loop Such a regulatory feedback mechanism explained how this oscillation of cellular protein levels emerged, but questions lingered. What controlled the frequency of the oscillations?

Michael Young identified yet another gene, double time, encoding the DBT protein that delayed the accumulation of the PER protein. This provided insight into how an oscillation is adjusted to more closely match a 24-hour cycle. The paradigm-shifting

discoveries by the laureates established key mechanistic principles for the biological clock. During the following years, other molecular components of the clockwork mechanism were elucidated, explaining its stability and function. For example, this year’s laureates identified additional proteins required for the activation of the period gene, as well as for the mechanism by which light can synchronize the clock.In the year 2016 Yoshinori Ohsumi, was awarded the Nobel Prize for work around Autophagy. The word autophagy originates from the Greek words auto-, meaning “self”, and phagein, meaning “to eat”.

Thus, autophagy denotes “self-eating”.

Ohsumi’s discoveries led to a new paradigm in our understanding of how the cell recycles its content. His discoveries opened the path to understanding the fundamental importance of autophagy in many physiological processes, such as in the adaptation to starvation or response to infection. Mutations in autophagy genes can cause disease, and the autophagic process is involved in several conditions including cancer and neurological disease. He used Yeast cells as models. Yeast cells are relatively easy to study and consequently, they are often used as a model for human cells.

They are particularly useful for the identification of genes that are important in complex cellular pathways. But Ohsumi faced a major challenge; yeast cells are small and their inner structures are not easily distinguished under the microscope and thus he was uncertain whether autophagy even existed in this organism. Ohsumi reasoned that if he could disrupt the degradation process in the vacuole while the process of autophagy was active, then autophagosomes should accumulate within the vacuole and become visible under the microscope. He therefore cultured mutated yeast lacking vacuolar degradation enzymes and simultaneously stimulated autophagy by starving the cells. The results were striking! Within hours, the vacuoles were filled with small vesicles that had not been degraded. The vesicles were autophagosomes and Ohsumi’s experiment proved that autophagy exists in yeast cells. But even more

importantly, he now had a method to identify and characterize key genes involved this process. This was a major breakthrough and Ohsumi published the results in 1992. Ohsumi now took advantage of his engineered yeast strains in which autophagosomes accumulated during starvation.

This accumulation should not occur if genes important for autophagy were inactivated. Ohsumi exposed the yeast cells to a chemical that randomly introduced mutations in many genes, and then he induced autophagy. His strategy worked! Within a year of his discovery of autophagy in yeast, Ohsumi had identified the first genes essential for autophagy. In his subsequent series of elegant studies, the proteins encoded by these genes were functionally characterized. The results showed that autophagy is controlled by a cascade of proteins and protein complexes, each regulating a distinct stage of autophagosome initiation and formation. Thanks to Ohsumi and others following in his footsteps, we now know that autophagy controls important physiological functions where cellular components need to be degraded and recycled. Autophagy can rapidly provide fuel for energy and building blocks for renewal of cellular components and is therefore essential for the cellular response to starvation and other types of stress. After infection, autophagy can eliminate invading intracellular bacteria and viruses. Autophagy contributes to embryo development and cell differentiation. Cells also use autophagy to eliminate damaged proteins and organelles, a quality control mechanism that is critical for counteracting the negative consequences of aging. In 2015, there were 2 prizes awarded in the field of Physiology & Medicine. The first was given to Tu Youyou for working on therapy against malaria, and the second was awarded to William Campbell & Santoshi Omura for their work on discovering novel therapy against roundworm parasite. To learn more about these amazing discoveries please tune in to the next session of Biotecnika’s very own podcast. Now let us have a look at this year’s greatest contribution benefiting mankind. There were a lot of tough competitors. To name a few we have, the mighty Microbiome, the Cancer-Virus Hunters, Check-point Inhibitors. Our anticipations came to a rest on this October 1st, when James P. Allison and Tasuku Honjo together received the award for their discovery of cancer therapy by inhibition of negative immune regulation. During the 1990s, in his laboratory at the University of California, Berkeley, James P. Allison studied the T-cell protein CTLA-4. He was one of several scientists who had made the observation that CTLA-4 functions as a brake on T cells. Other research teams exploited the mechanism as a target in the treatment of autoimmune disease. Allison, however, had an entirely different idea. He had already developed an antibody that could bind to CTLA-4 and block its function.

Listen the complete episode at https://soundcloud.com/biotecnika

PH.D. ADMISSIONS

October 23rd, 2018 Vol. 02 NO 49

5

BIT Mesra PhD Program Session Spring (January) 2019 Admissions Birla Institute of Technology, Mesra (BIT Mesra) is an Indian institute of higher education and a deemed University under Section 3 of the UGC Act. It was established in the year 1955 at Mesra, Ranchi in the state of Jharkhand, India by the philanthropist and industrialist Late Shri. B. M. Birla.

BIT MESRA PHD PROGRAM SESSION SPRING (JANUARY) 2019 ADMISSIONS ANNOUNCEMENT HAS BEEN MADE. BIT MESRA PHD ADMISSION PROGRAM SESSION SPRING (JANUARY) 2019. BIT MESRA PHD ADMISSIONS 2019. INTERESTED AND ELIGIBLE CAN CHECK OUT ALL OF THE DETAILS ON THE SAME BELOW

By Diluxi Arya

PH.D. ADMISSION NOTIFICATION (FULL-TIME / PART-TIME) FOR THE SESSION SPRING 2019 BIRLA INSTITUTE OF TECHNOLOGY (Deemed to be University u/s 3 of UGC Act 1956) MESRA, RANCHI – 835215 (INDIA) Eligibility Criteria: Candidates with following qualification shall be eligible for admission to the Ph. D. Program of the Institute: (a) Candidates possessing M.Tech./M.E./M.Sc. (Engg.)/M.Arch./M.Pharm./M.Plan./M.Sc./MCA/ MBA or equivalent Degree in relevant branch from a recognized University/Institute with minimum 60% marks or 6.0 CGPA on a ten point scale in the qualifying examination are eligible to apply for admission in the relevant departments. (b) Candidates possessing B.Tech./B.E/B. Sc.(Engg.)/B.Pharm/B.Arch./B.Plan. or equivalent Degree in relevant branch from a recognized University/Institute with a minimum of 80% marks or 8.0 CGPA on a ten point scale in the qualifying examination and a valid GATE/GPAT score with a minimum of 80 percentile are eligible to apply for admission in the departments as per their Specialization. (In this case, the candidates need to pass in more numbers of qualifying Pre-PhD papers; the concerned detail is described in PhD Ordinance 2018 -Section 9.1). (c) Sponsored candidates must have a minimum of two years of professional work experience, besides fulfilling the above criteria. In addition, such candidates should have valid sponsorship at least for three years.

RELAXATION FOR SC/ ST CANDIDATES Eligibility criteria will be relaxed by 5% marks for SC / ST candidates.

Note: 1. NOC from the Institute is mandatory for employees of the Institute which shall be obtained before appearing at the admission test for the PhD program.

2. Employees from other organizations shall produce NOC from his/her respective employers at the time of admission.

3. In case of the candidates with other grade point scale, the decision of the equivalence made by the assigned committee of the Institute shall be final.

Fellowship Available: A limited number of Institute Research Fellowship (IRF) with a fellowship amount of Rs. 25,000/- per month for first two years and Rs. 28,000/- per month for the next two years is available. These IRFs shall be distributed based on the performance in the admission test, academic carrier and interview. PhD admission test is mandatory for the candidate aspiring for the IRF.

How to Apply: 1. To start the online application, click on the link, create ‘username’ and ‘password’ by clicking on “New users register here” when prompted. Do not share the username and password with anybody else.

2. To apply for the PhD program (Session Spring 2019), eligible candidates must complete and submit the application online [link available on Institute website www.bitmesra.ac.in]. Pay application fee through State Bank Collect (any nationalized bank) of Rs.2,950/- (General candidates) and Rs.1,770/(for SC/ST candidates). Fee once remitted shall not be refunded under any circumstances.

3. Send a printout of the completed application form along with required enclosures (see List of Enclosures) in an A4 size envelope by Speedpost / reliable courier (means by which sender may track its movement on the internet) to the office of Dean, Admissions & Academic Coordination, Birla Institute of Technology, Mesra, Ranchi – 835215, to reach positively by the due date.

4. Write “Application for Ph.D. Admission (Session Spring 2019)” on top of the envelope.

5. Applications reaching us after the due date are liable to be rejected / may not be processed.

6. Please do not print a blank form and fill it

Important Dates:

by hand as this will not be accepted.

Contact Details: Dean, Admissions & Academic Coordination, Birla Institute of Technology, Mesra, Ranchi – 835 215 Phone: PBX: 0651-2275444 / 896, Extn. 4469, and 0651-2275868 (Direct) E-mail: admissions@bitmesra.ac.in, dean.aac@ bitmesra.ac.in For any queries, candidates should see PhD Ordinance 2018 available on the Institute website (downloadable as pdf document). For any further queries, candidates may contact the Dean, Academic Programme through e-mail at dean.ap@bitmesra.ac.in.

For any queries about the research areas and syllabi of the Tests, candidates may please contact the concerned Head of the Department by telephone or e-mail. (Please see Directory on the Institute website for contact details).

Candidates must visit our website http://www. bitmesra.ac.in regularly for updates and/or for any other matters related to the admission procedures

6

PH.D. ADMISSIONS

October 23rd, 2018 Vol. 02 NO 49

IIT Delhi Admission PhD/MS (Research) Programmes 2018-2019 The IIT Delhi has the status of Institute of Eminence (IoE) which graded full autonomy, leaving this institutes to make their own decisions. According to a government statement issued earlier, these IoEs will have greater autonomy in that they will be able to admit foreign students up to 30% of the admitted students and recruit foreign faculty up to 25% of the faculty strength. of the qualifying examination.) A relaxation in CGPA/marks to 5.50 / 55 percent can also be available to people who have M.A. Degree in English, for admission to PhD in Humanities and Social Sciences. For admission to Ph.D./ M.S. (R) programmes, the qualifying GATE Score of a candidate, where required, shouldn’t be lower than the minimum prescribed. The requirement of GATE/ National Exam is waived for a few graduates/students from CFTIs. For information, please consult with the Information Brochure.

Financial Assistance is available for PhD / M.S.(R) pupils according to details given in the Information Brochure.SC/ST/PH pupils are exempted from payment of tuition fee. 5.

IIT DELHI ADMISSION TO PH.D./ M.S.(RESEARCH) PROGRAMMES 2018-2019 (2ND SEMESTER) ANNOUNCEMENT HAS BEEN MADE. MSC AND PHD RESEARCH PROGRAMMES 2018-2019 AT IIT DELHI. INTERESTED CANDIDATES CAN CHECK OUT ALL OF THE DETAILS ON THE COURSES, ELIGBILITY AND APPLICATION PROCEDURE BELOW

By Diluxi Arya

INDIAN INSTITUTE OF TECHNOLOGY DELHI HAUZ KHAS, NEW DELHI-110016 ADMISSION TO Ph.D./ M.S.(RESEARCH)

PROGRAMMES 2018-2019 (2nd Semester) PhD: Depts: Appl. Mech., Biochem. Engg. & Biotech., Chem. Engg., Chemistry, Civil Engg., Comp. Sci. & Engg., Elect. Engg., Hum. & Soc. Sci., Management Studies, Maths, Materials Science and Engg., Mech. Engg., Physics, Text.

Tech., Design.

Centres: Appl. Res. in Electron., Atmos. Sci., Biomed. Engg., Energy Studies, Ind. Tribology Machine Dynamics & Maint. Engg., Instr.

Design & Dev., National Resource Centre for Value Education in Engineering, Rural Dev. & Tech.

Schools: Amar Nath and Shashi Khosla School of Information Tech., Bharti School of Telecom. Tech. and Management, Kusuma School of Biological Sciences, School of Inter-

https://stores.biotecnika.org

disciplinary Research.

Interdisciplinary Research Programme: Transportation Research & Injury Prevention Prog.

M. S. (Research): (1) Appl. Mech. (2) Chem.

Engg. (3) Civil Engg. (4) Comp. Sc. & Engg.

(5) Elect. Engg. (6) Mech. Engg. (7) Amar Nath and Shashi Khosla School of Information Tech.

(8) Bharti School of Telecommunication Tech. & Managt. (9) Kusuma School of Biological Sciences.

NB: Admission to Ph. D. & M.S. (R) can be on full time and Part-time basis Eligibility: A CGPA of 6.00 for General/OBC (5.50 for SC/ST/PH) on a 10 point scale or equivalent or 60% marks (55 percent for SC/ ST/ PH) in aggregate (of all the years/semesters

Application Procedure: Submission of Application is simply through online portal. Candidates are NOT required to send hard copy of the application form. Online submission of application form could be made by accessing the Institute website < www.iitd.ac.in/pgadmission >. Please see the detailed instructions provided in the Information Brochure. Candidates belonging to General / OBC category are required to pay for each application form a fee of Rs. 200/and the applicants belonging to SC/ST/PH categories are needed to pay Rs. 50/-. The bank charges will be borne by the candidate.

Foreign nationals aren’t eligible to apply against this particular advertisement.

Important Dates: Submission of online Application commences on 15.10.2018 Last date for submission of online application 30.10.2018

PH.D. ADMISSIONS

October 23rd, 2018 Vol. 02 NO 49

7

ICMR Submission of Concept Proposals on “Dengue Viral Disease” ICMR Call for Submission of Concept Proposals on “Dengue Viral Disease” announcement has been made.

CALL FOR SUBMISSION OF CONCEPT PROPOSALS ON “DENGUE VIRAL DISEASE”ANNOUNCEMENT RELEASED. CHECK OUT ALL DETAILS ON THE BACKGROUND, INSTRUCTIONS FOR SUBMITTING CONCEPT PROPOSALS, AND MORE BELOW

By Diluxi Arya

Background: The incidence of dengue has grown dramatically around the world in recent decades. Over 2.5 billion people i.e. 40% of the world’s population are now at risk from dengue. WHO currently estimates there may be 50–100 million dengue infections worldwide every year. Before 1970, only nine countries had experienced severe dengue epidemics. The disease is now endemic in more than 100 countries in Africa, the Americas, the Eastern Mediterranean, South-east Asia and the Western Pacific.

In India, the first epidemic of clinical dengue-like illness was recorded in Chennai in 1780 and the first virologically proven epidemic of dengue fever (DF) occurred in Kolkata and Eastern Coast of India in 1963-1964. The DHF started simmering in various parts of India since 1988. The first major wide spread epidemic of DHF/DSS occurred in Northern India in 1996 involving areas around Delhi and Lucknow and then it spread to all over the country. As of now, seasonal outbreaks of Dengue are widespread and occur in almost all parts of the country.

There is ambiguity in all spheres of diagnosis and clinical management of dengue patients’ due to several reasons: lack of well-defined diagnostic algorithm for Acute Febrile Illness (AFI); unsurmountable diagnostic dilemmas due to variation in types of dengue diagnostic kits to be used as per duration of onset of illness; rampant mushrooming of rapid diagnostic kits with unknown sensitivity and specificity; lack of reliable point of care test for diagnosis of dengue; lack of clarity on maintaining appropriate hydration status of the patient often leading to over-hydration and cardiac failure etc. It is critical to identify research gaps related to clinical and laboratory identification as well as management of patients of dengue and prioritizing research to address various issues which could eventually lead to improved patient outcomes.

II. Interested Investigators are invited to submit a two – three page (A4 size) Concept Proposals pertaining to the following research areas: 1. Epidemiological research questions: a. Proportion of asymptomatic dengue responsible for disease transmission. b. Correlation of various dengue serotypes and genotypes with disease severity.

c. Establish incidence of dengue disease through cohort based studies in outbreak prone areas.

2. Clinical research questions: a. Corroborate the severity of disease with viral load. b. Develop age specific guidelines for use of fluids in dengue patients. c. Develop explicit guidelines for platelet transfusion in DHF/DSS. d. Role of endothelium stabilizing agents in decelerating vascular leakage and haemo-concentration. e. Effect of co-morbidities like diabetes, hypertension, coronary artery disease and obesity on disease severity.

3.

Basic research q u e s tions: a .

Individual o r

strategies: a. Innovative strategies for community engagement. b. Novel methods for Information, Education and Communication (IEC) for control of dengue and chikungunya.

III. Instructions for submitting Concept Proposals: A. A brief (two -three pages) Concept Proposals should be submitted under the following headings: i. Title of the Study ii. Need for the Study iii. Objectives of Research iv. Novelty of Research v. Brief Methodology vi. Applicability & Proposed out-

4. Community engagement

Investigators should select Broad Area as “Epidemiology & Communicable Diseases” and major discipline as “Viral Diseases”.

The Investigator should select Dr. Nivedita Gupta as the Programme Officer.

In case of queries related to online submission, please contact ICMR online team at Ph: 011-26588590. Email: onlineicmrteam@gmail.com.

C. Time Line: Last Date for submission of Concept Proposals / End Date: 07th November 2018

host chara c t e ristics responsible for asymptomatic course of the disease. b. Immuno-pathogenic mechanisms in symptomatic versus asymptomatic disease. c. Define the molecular markers and biomarkers to predict disease severity. d. Impact of coagulation disorders and platelet dysfunctional disease on severity of dengue disease.

http://icmrextramural.in/ICMR/.

Interested researchers should avail the “Online submission of extramural research projects” facility available at the ICMR website (http://www.icmr. nic.in/ ). They would need to register themselves with the online submission system. Complete guidelines for the same have been provided on the website (www.icmrextramural.in ); the same should be strictly followed. PIs already registered need not register again.

D. Review:

lines)

come vii.

Collaborators with assigned roles viii. Duration of the study ix. Ball park budget x. Competence of the PI (10-12

B. Instructions for submitting Concept Proposals: The applicants should submit Concept Proposals through the ICMR electronic project management system (ePPMS)

Concept Proposals will be screened at ICMR. PIs of the selected Concept Proposals will be contacted within 2-4 weeks of the end date for submission of applications and will be requested for submission of Full proposals.

E. Contact Person: Dr. Nivedita Gupta; Scientist E (Email: dengue.ecd@gmail.com and Ph: 011-26589397), Division of Epidemiology & Communicable Diseases (Room No. 315); Indian Council of Medical Research; Ansari Nagar; New Delhi – 110029; India

8

NEWS

October 23rd, 2018 Vol. 02 NO 49

Important Notice From CSIR Regarding Issue of Certificates Council of Scientific & Industrial Research (CSIR), India, a premier national R&D organisation, is among the world’s largest publicly funded R&D organisation. CSIR’s pioneering sustained contribution to S&T human resource development is acclaimed nationally.

1. Mark Statement 2. Admit Card 3. Xth class certificate as a proof of date of birth 4. Degree/provisional degree of qualifying exam /M.Sc. or equivalent degree 5. Final mark sheet with the required percentage of marks 6. CGPA/SGPA/OGPA/CPI etc conversion formula of their respective University/Institute or certificate from concerned University/ Institute clearly stating the percentage of marks in the qualifying degree 7. Bifurcation of marks/period in case of dual degree 8. Caste certificate, if applicable 9. OBC candidates are required to submit their latest OBC caste certificate (Non creamy layer) as per format given in NCBC website (www.ncbc.nic.in) 10. PwD candidates should submit certificates as per Govt. of India rules.

CSIR’S RENEWED MISSION IS INSPIRED BY THE REMARKS MADE BY PRESIDENT OF CSIR SOCIETY TO CSIR TO BUILD”..THE NEW CSIR THAT WILL FULFILL THE ASPIRATIONS OF MODERN INDIA…” SO CSIR’S MISSION IS SIMPLY – TO BUILD A NEW CSIR FOR A NEW INDIA

By Diluxi Arya

NOTICE (ATTENTION: QUALIFIED CANDIDATES OF JUNE 2017 AND DECEMBER, 2017 CSIR-UGC-NET) (ISSUE OF CERTIFICATES) THE CERTIFICATES OF CANDIDATES HAVING THEIR ROLL NUMBERS IN PART-I OF RESULT (CSIR JRF/LS AND JRF ONLY) WILL BE ISSUED BY EXAMINATION UNIT, CSIR COMPLEX, NEW DELHI THE CERTIFICATES OF CANDIDATES HAVING THEIR ROLL NUMBERS IN PARTII AND PART-III OF THE RESULT (CSIR JRF/

LS AND LECTURERSHIP ONLY) WILL BE ISSUED BY UNIVERSITY GRANT COMMISSION OFFICE, DELHI UNIVERSITY, SOUTH CAMPUS, BENITO JUREZ MARG, NEW DELHI-110021. WEBSITE INFORMATION (WWW.UGCNETONLINE.IN) THE CANDIDATES WHO HAVE QUALIFIED UNDER (CSIR JRF/LS AND JRF ONLY) PART-1 OF THE RESULT IN DECEMBER, 2017 EXAM ARE REQUIRED TO SEND SELF ATTESTED PHOTOCOPIES OF THE FOLLOWING DOCUMENTS THROUGH ORDINARY POST.

Candidates who have applied under the Result Awaited (RA) category (MSc or equivalent) should submit the required documents only after completion of their requisite qualifications Candidates are required to send the above-mentioned documents by Ordinary Post to Section Officer, Certificate Section, HRD Group, CSIR Complex, Library, Avenue Road, Pusa, New Delhi – 110012.

Candidates while sending their documents must super-scribe on the envelope “Documents for December – 2017 NET Exam and Roll No___________________.”

Novartis acquires Endocyte for 2.1 Billion Cash deal The announcement of Novartis acquires Endocyte deal came months after Endocyte declared the U.S. Food and Drug Administration (FDA) accepted radiographic progression-free survival instead of the main endpoint in its Phase III VISION trial, that will inspect the provider’s Lu-PSMA-617 program for treating metastatic castration-resistant prostate cancer (mCRPC).

SHARES OF INDIANA-BASED ENDOCYTE H A V E TA K E N U P M O R E THAN 50 PERCENT IN PRE-MARKET TRADING F O L LO W I N G S W I S S P H A R M A G I A N T N O VA R T I S D E C L A R E D T H AT I T WA S A C Q U I R I N G T H E C O M PA N Y FOR $2.1 BILLION IN CASH

By Shekhar Suman

The deal will enable the company to expand its radiopharmaceuticals business.

The rPFS endpoint will be to survival in addition.

In its announcement, Novartis said Lu-PSMA-617 is a possible treatment for mCRPC. Earlier this year Endocyte published Stage II data that

revealed patients dosed with Lu-PSMA-617 saw high levels of PSA response, even those patients who were heavily pretreated.

Novartis said its RLT platform will be expanded by Endocyte’s purchase with a possible product launching and clinical development programs. The company said it will allow Novartis to research Lu-PSMA-617 as a treatment for traces of prostate therapy.

Why Novartis acquires Endocyte?

Chief executive officer of Novartis Oncology, Liz Barrett, said Endocyte’s purchase builds on the business’s growing capacity in radiopharmaceuticals. She noted that is

expected to become a growth driver for the company business, in addition to an important treatment option for patients. Radiopharmaceuticals such as the Lu-PSMA-617 of Endocyte are medicinal formulations containing radioisotopes used clinically for treatment and diagnosis.

chase that supplied a vital radioligand treatment — Lutathera, the first ever approved Peptide Receptor Radionuclide Therapy. Lutathera was approved in January for treating somatostatin-receptor favorable gastroenteropancreatic neuroendocrine tumors (GEP-NETs), an orphan disease.

“We’re also excited about the chance to break in the prostate cancer arena using a near-term product which has the potential to generate a significant impact for patients in good need of more choices,” Barrett said in a statement.

Mike Sherman, Endocyte’s CEO, said the company is thrilled that Novartis sees possible for Lu-PSMA-617 to alter the treatment landscape for mCRPC, in addition to the wider role that radioligand therapies could play in cancer.

The purchase of Endocyte comes about a year after Novartis snapped French cancer company Advanced Accelerator Applications at a $3.9 billion pur-

“The global reach and experience of Novartis in developing and commercializing RLT therapies will be crucial in efforts for individuals to benefit from such therapies as soon as possible,” Sherman said in a statement.

NEWS

October 23rd, 2018 Vol. 02 NO 49

9

Pfizer Announces Jobs Cuts Worldwide Citing structural simplification, Pfizer declared it intends to cut its international staffing by about 2 percent. It expects to do so through early retirement and layoffs in 2019 at the end of this year and early.

THE BUSINESS EMPLOYS OVER 90,000 PEOPLE. PFIZER SAID THAT BRANCHES AND ALL BUSINESS UNITS ARE LIKELY TO BE AFFECTED, TOGETHER WITH THE REDUCTIONS FOCUSED ON EMPLOYEES

By Diluxi Arya

Sally Beatty, Pfizer spokeswoman, told CNBC, “As we prepare for expansion we’re creating a more efficient construction which can influence some managerial functions and responsibilities. We’re offering enhancements to certain advantages to lessen this impact.”

The chief executive officer will be Albert Bourla, who’s currently the chief operating officer of Pfizer.

Last week, Bourla declared changes to the executive team which will occur on January 1.

This also follows a July statement that Pfizer was reorganizing into three components, dividing its consumer healthcare until that it had previously been trying to market. The components will be Innovative Medicines, which will contain a Consumer Healthcare unit and a hospital company unit for sterile and anti-infectives injecta-

bles; a branded and Launched Medicines business unit; and biosimilars. The changes are expected to go into effect at the start of the 2019 year of Pfizer.

“As we transition into a period post2020 where we anticipate a higher and more sustained revenue growth profile we view that this new structure better positioning every business to realize its growth potential.”

In a statement to employees concern-

ing the layoffs, Pfizer said, “To realize our full potential we’ll have to create a simpler and more efficient company.

As we simplify the business to prevent duplication, create single points of accountability and reduce the number of layers within groups, there’ll be an impact to managerial functions and responsibilities throughout the organization.”

Pfizer is currently offering severance packages salary of 12 weeks, and three

weeks of salary for each year of work.

Employees who volunteer for retirement may take any equity that is vested together with other benefits, health insurance and them at prices for up to three decades. Those who have been with the business at least 10 years and are 55 years old may qualify for retirement. They have to opt into the retirement program. Unless their supervisor asks they remain a couple of months 21, They’ll have the ability to exit the business.

10

EXCLUSIVE M.SC. & PH.D. JOBS

October 23rd, 2018 Vol. 02 NO 49

SVP National Police Academy Recruitment With Rs. 1.7 Lakh Salary pm

G

overnment jobs for msc botany, zoology, microbiology, biochemistry, biology scientific officer vacancies at SVP National Police Academy, Hyderabad. Sardar Vallabhbhai Patel National Police Academy, Hyderabad October 2018 Recruitment. Interested and eligible candidates check out all of the details on the same below: SARDAR VALLABHBHAI PATEL NATIONAL POLICE ACADEMY (Government of India : Ministry of Home Affairs) Shivarampally, Hyderabad – 500 052

Designation: Assistant Director (Scientific Aids) No. of Posts: 01 Scale of Pay: PB-3 (Rs.15600-39100/-) +Grade Pay Rs.5400/-. (Revised: Level-10 Rs. 56100-177500/-) Qualification: Candidates possessing the following educational qualifications and experience: (i) Master’s Degree in Forensic Science/ Chemistry/Genetics/ Zoology/Botany/Biochemistry/Molecular Biology/ Human Biology of a recognized Unversity or equivalent.

(ii) Five years analytical work experience in Biology/ Serology/ DNA/ Narcotics in any of the Central/ State Forensic Laboratories as Senior Scientific Officer/ Junior Scientific Officer with experience in the investigation at the scenes of the crimes.

Desirable (i) Ph.D in the applicable subject mentioned.

Nature of Duties : The Assistant Director (Scientific Aids) will be in-charge of the Forensic Science Section in the Academy and shall be responsible for the efficient working of the Forensic Section. He is required to teach the subject of Forensic Science for the basic courses and in-service

MSc Biosciences Lab Associate/Manager Posts With Salary of Rs. 50,000/- p.m. @ NCCS

C

andidates with MSc Biosciences and Life Sciences are encouraged to apply for Laboratory associate/manager posts at NCCS. NCCS, Pune is recruiting for Laboratory associate/manager vacancies. MSc Bio/Lifesciences candidates apply for a research positions that are available at NCCS details given below: Advt. No. NCCS/Project Management Cell/P0 08/2018 Post I Designation: Laboratory Manager, Tier II, Grade C for microscopy Project Name: Establishment of A Pune Biotech Cluster, “Model Organism to Human Disease.”

Essential: M.Sc. Or Equivalent Degree with 1-year experience or B.Sc. With 5 years of expertise.

Desirable: Must possess excellent experience in handling a Bio-Imaging (Microscopy) instrumental center and outstanding team handling capacities.

Monthly Emoluments: Rs. 50,000/(Fixed) Post II Designation: Technical / Lab Associate (Tier 1 Grade B) Project Name: Establishment of A Pune Biotech Cluster, “Model Organism to Human Disease.”

Essential: M. Sc. Or equal degree with a

minimum of 55% marks in almost any branch of life science.

Desirable: Experience in tackling high-end Microscopes and/or LC-MS Monthly Emoluments: Rs. 28,000/(Fixed) Application Instructions: Applications in the prescribed format duly filled in along with attested copies of all relevant certificates showing date of birth, educational qualifications, work experience, details of the examination passed (Secondary School Certificate onwards), caste certificate, if any and other relevant documents must reach”The Director, National Centre For Cell Science (NCCS), S. P. Pune University Campus, Post: Ganeshkhind, Pune — 411 007, Maharashtra, India before or on 31.10.2018.

• List of shortlisted candidates called for in-

courses. He will also be responsible for conducting courses, seminars and workshops assigned to him when nominated as Course Coordinator.

How to Apply: Candidates fulfilling the eligibility criteria may report at this Academy (Site-B) for selection process on 15.11.2018 at 1300 hrs along with prescribed application form duly filled and one set of attested copies of educational qualification certificates, experience certificates including copy of Pension Payment Order (for retired officers) Date & Time of Interview: 15.11.2018 at 13:00 hrs

NCCS terview, date and time of interview & other pertinent information will be published on our Institute site on or before 20.11.2018.

• The interviews have been scheduled on 11,12 & 13th December 2018 • Applications received after the expected date/due to postal delay and/or without the copies of the required certificates/documents will not be considered.

Applications which are incomplete and/or not from the prescribed format will be rigorously rejected.

Please bring all of the original certifications showing date of birth, eligibility, statement of marks of the examination passed, degree certificates, certificate of past experience, certificate in support of present employment, salary certificate & other relevant documents along with a set of attested copies at the time of interview.

ICMR Hiring MSc Microbiology Candidates for SRF Position

M

Sc Microbiology candidates to apply for the Senior Research Fellow position that is available at ICMR, New Delhi.

ICMR Recruitment 2018 for msc microbiology candidates for SRF position. SRF Microbiology jobs for msc candidates at ICMR. ICMR recruiting as per the details given below: Position: SRF- One Post Title of the Project: “Neo AMR Global Neonatal Sepsis Observational Study (NEO OBS)” Salary: Rs 36,400/-pm consolidated Upper age limit: 35 yrs Qualifications: a. Postgraduate Degree in Microbiology/ Professional Course b. Two years of research expertise Desirable Qualification: A. Experience of

working on automated systems for ID/AST/ Molecular labs. B. Awareness of computers Age Limit: Not exceeding 35 years. Age relaxation is for SC, ST & OBC candidates as per Govt. Rules. No Age relaxation contrary to the Unreserved vacancies according to Govt. of India order No. 36011/1/98/Estt(Res) dated 1/7/1998 Salary: Consolidated Salary of Rs.48,000/p.m. + HRA as per rules How to Apply: These posts are to be filled up on purely temporary basis until the project lasts. The appointment may be terminated with a onemonth notice from either side without assigning any reason.

Since the posts are purely temporary, the incumbents chosen will not have any claim for routine appointments beneath ICMR/LHMC or continuation of their services in any other project, the benefit of the provident fund,

HRA, CCA, Leave Travel Concession, Medical Claim etc. isn’t applicable. Age relaxation is for SC, ST & OBC candidates as per Govt.

Rules. Canvassing in any form will be a disqualification. No TA/DA etc. will be awarded to attend the walk-in-interview.

A walk-in interview for the aforementioned post will be held on 5th November 2018 for Posts 1-3 and on 9th November 2018 for Posts 4-5. The candidate has to be present by 10.00 AM and also bring the filled application in the prescribed format, CV, and photocopies of educational qualifications and work experience to Room no 118, Kalawati Saran Children’s Hospital, New Delhi 110001 (Contact person Mr Pradeep). All candidates should provide valid email identification and cellular number for additional communication.

Details of Application Form can be found at the website of Lady Hardinge Medical College: http://lhmc-hosp.gov.in/ A screening written exam may be held based on the number of applicants.

Candidates must report between 9-10 AM at the Seminar Room, 1st Floor, Old Building, Kalawati Saran Children’s Hospital, New Delhi 110 001.

Those candidates must bring together (1) Each of certificates/testimonials in original (2) One attested copy all the certifications (3) Four copies of brief curriculum vitae as per proforma enclosed, (4) one passport size recent colour photograph and (5) Filled the application form in the prescribed format.

Dr. Sushma Nangia (drsnangia@gmail.com) Principal Investigator & Director Professor & Head Department of Neonatology LHMC & KSCH Hospital, New Delhi Dr. Suvasini Sharma (Sharma.suvasini@gmail.com) Member Secretary Research and Project Committee LHMC & KSCH Hospital, New Delhi

EXCLUSIVE M.SC. & PH.D. JOBS

October 23rd, 2018 Vol. 02 NO 49

11

MSc Officer Quality Control Posts Vacant @ Jubilant Generics Limited

M

Sc Microbiology Jobs at Jubilant Generics Limited. Jubilant Generics Limited Hiring for Officer Quality Control Position. Officer Quality Control post for msc microbiology candidates. MSc microbiology jobs with relevant experience for eligible candidates. Apply Online.

Check details on the same, that have been posted below:

To examine the microbiology samples of materials and to keep Good microbiology practices. Should possess knowledge of handling devices like Autoclave, Air sampler, Compressed Air sample.

Name of the Position: Officer-Quality Control

• Responsible for various sampling analysis of RM / Water samples / Swab samples / Compressed Air Monitoring / Microbial load in production areas.

Location: Roorkee – Plant, IND Function: Quality Job Description: Summary of Job – Officer – QC Micro

Micro identification instruments.

Key Responsibilities (Performance Indicators)

• Recording of Analytical data.

• Maintenance of standard media & cultures utilized in the lab.

• MLT Validation

GLP in the defined activities.

• Strict adherence to SOP’s / STPs and GTP’s.

• To ensure the timely launch of material according to schedules.

• to guarantee proper storage and destruction of samples following testing.

• Validation/calibration of all Instruments, equipment etc..

• Preparation of worksheets for RM / Finished products / Water samples / Swab Samples.

• To guarantee compliance of cGMP and

• Investigation of deviations, incidents and OOS Qualifications & Experience M.Sc (Microbiology) with 2-4 Years experience in microbiology analysis in a regulatory reputed Pharmaceutical unit.

Key Competencies (Technical, Functional & Behavioural) • Analytical abilities According to different Pharmacopoeia Methods • Exposure to method Validation is essential • Communication skills & Analytical Skills

Microbiologist Position Vacant @ Britannia Industries Limited

I

f you are a graduate from a background with Microbiology as a qualification, then make sure you apply online for Microbiologist position. Microbiologist post for microbiology candidates is available at Britannia. Interested candidates can apply according to the details that have been posted below: Title: Microbiologist – 1 Opening(s) Expertise: 4 – 6 Years Location: Mundra Basic knowledge of applicable software to infer statistical data. Negotiation skills. Customer Orientation, Interpersonal skills.

Key Duties:

cords

Header: Quality & Food Safety Execution

4) Regular follow up on chemicals/ reagents/ apparatus is done in Order to Make Sure That reliability in testing is ensured

1) Ensure Microbiological & food safety compliance of all the raw materials in use through testing & complying of Ingredients.

2) Conduct microbiological testing of finished goods/Area, equipment & hand swab according to standard sampling & test method with correct documentation. Conduct chemical/sensorial analysis as per SOP so that its compliance is ensured.

3) Periodical confirmation of process records, incoming quality check records, ingredient shelf-life records, in-process quality check re-

Header: Statutory Compliance

5) Ensure basic hygiene & safety norms are complied with in the laboratory 6) Conduct training sessions for workers & Lab Assistants to create awareness on laboratory testing & safety norms 7) Conduct regular audit of systems, processes connected to laboratory functioning to verify compliance Outcomes expected: Compliance to standards

1) Ensure food packaging have been compiled as statutory requirements through checks laminate / CBB declarations, PCRO panel compliance, nutritional compliance and essential documentation is maintained 2) Ensure all weighing balances, dead weights and testing equipment identified, are stamped/ calibrated as per schedule & not in use without necessary certification Outcomes expected: Packs & Products complying to statutory requirements

Freshers Biotech & Food Tech Quality Analyst @ PerkinElmer India

F

reshers msc biotechnology and msc food technology candidates are requested to apply for Quality Analyst vacancies at PerkinElmer India Pvt. Ltd. Freshers msc biosciences candidates are encouraged to quality analyst jobs at PerkinElmer India.

Check out all of the details on the same below:

Functional Area: Other Role: Other Employment Type: Permanent Job, Full Time Job Description: Job Profile:

Job Name: Quality Analyst

1. Instrument operation

Openings: 4

2. Data interpretation

Experience: 0 – 2 yrs

3. Application on the instrument

Locations: Kochi, Imphal, Panjim Salary: Not Disclosed by Recruiter Industry: Pharma / Biotech / Clinical Research

3. Cochin (1 Opening)

knowledge of analytical instruments • Experience: 0-2 years

Education:

• Freshers are can also apply.

• Postgraduate in Biotechnology/Organic Chemistry/Inorganic Chemistry/Food Technology or any relevant fields

How to Apply:

• Candidate should have good technical

Interested candidates can apply for the vacancies via an email at recruitment.india@perkinelmer. com

We have multiple openings 1. Manipur (2 Openings) 2. Goa (1 Opening)

YOUR CSIR PARTNER

12

October 23rd, 2018 Vol. 02 NO 49